Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 3927096, 7 pages
https://doi.org/10.1155/2018/3927096
Research Article

Shaofu Zhuyu Decoction Regresses Endometriotic Lesions in a Rat Model

1College of Traditional Chinese Medicine, North China University of Science and Technology, No. 21 Bohai Road, Caofeidian Xincheng, Tangshan, Hebei 063210, China
2Guang’anmen Hospital, China Academy of Chinese Medical Sciences, No. 5 Beixiange, Xicheng District, Beijing, China

Correspondence should be addressed to Ying Cao; moc.361@20ynuoc

Received 17 September 2017; Revised 13 December 2017; Accepted 19 December 2017; Published 30 January 2018

Academic Editor: Hyunsu Bae

Copyright © 2018 Guanghui Zhu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. A. Rogers, T. M. D'Hooghe, and A. Fazleabas, “Priorities for endometriosis research: recommendations from an international consensus workshop,” Reproductive Sciences, vol. 16, no. 4, pp. 335–346, 2009. View at Publisher · View at Google Scholar
  2. P. Vercellini, P. Viganò, E. Somigliana, and L. Fedele, “Endometriosis: pathogenesis and treatment,” Nature Reviews Endocrinology, vol. 10, no. 5, pp. 261–275, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Muñoz-Hernando, J. L. Muñoz-Gonzalez, L. Marqueta-Marques et al., “Endometriosis: Alternative methods of medical treatment,” International Journal of Women's Health, vol. 7, pp. 595–603, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Zito, S. Luppi, E. Giolo et al., “Medical treatments for endometriosis-associated pelvic pain,” BioMed Research International, vol. 2014, Article ID 191967, 12 pages, 2014. View at Publisher · View at Google Scholar
  5. I. Streuli, D. De Ziegler, P. Santulli et al., “An update on the pharmacological management of endometriosis,” Expert Opinion on Pharmacotherapy, vol. 14, no. 3, pp. 291–305, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. S.-W. Guo, “Recurrence of endometriosis and its control,” Human Reproduction Update, vol. 15, no. 4, pp. 441–461, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Normile, “The new face of traditional Chinese medicine,” Science, vol. 299, no. 5604, pp. 188–190, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Chao, Y. Dai, R. Verpoorte et al., “Major achievements of evidence-based traditional Chinese medicine in treating major diseases,” Biochemical Pharmacology, vol. 139, pp. 94–104, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Zhou and F. Qu, “Treating gynaecological disorders with traditional Chinese medicine: a review,” African Journal of Traditional, Complementary and Alternative Medicines, vol. 6, no. 4, 2010. View at Publisher · View at Google Scholar
  10. R.-H. Zhao, Z.-P. Hao, Y. Zhang et al., “Controlling the recurrence of pelvic endometriosis after a conservative operation: Comparison between Chinese herbal medicine and western medicine,” Chinese Journal of Integrative Medicine, vol. 19, no. 11, pp. 820–825, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Flower, J. P. Liu, G. Lewith, P. Little, and Q. Li, “Chinese herbal medicine for endometriosis,” Cochrane Database of Systematic Reviews, vol. 5, p. CD006568, 2012. View at Google Scholar · View at Scopus
  12. P. Tsai, Y. Lin, J. Chen, S. Yang, Y. Chen, and H. Chen, “Identifying Chinese Herbal Medicine Network for Endometriosis: Implications from a Population-Based Database in Taiwan,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, pp. 1–10, 2017. View at Publisher · View at Google Scholar
  13. M. W. Vernon and E. A. Wilson, “Studies on the surgical induction of endometriosis in the rat,” Fertility and Sterility, vol. 44, no. 5, pp. 684–694, 1985. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Chu, T. Jiang, C. Tang, and M. Yangand, “Optimizing the establishment of endometriosis model in rats by orthogonal experiment,” Chinese Pharmcological bulletin, vol. 25, no. 7, pp. 973–975, 2009 (Chinese). View at Google Scholar
  15. S. Reagan-Shaw, M. Nihal, and N. Ahmad, “Dose translation from animal to human studies revisited,” The FASEB Journal, vol. 22, no. 3, pp. 659–661, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Yilmaz, M. Ozat, S. Kilic et al., “Atorvastatin causes regression of endometriotic implants in a rat model,” Reproductive BioMedicine Online, vol. 20, no. 2, pp. 291–299, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Mehedintu, M. N. Plotogea, S. Ionescu, and M. Antonovici, “Endometriosis still a challenge,” Journal of Medicine and Life, vol. 7, no. 3, pp. 349–357, 2014. View at Google Scholar
  18. A. D. Greene, S. A. Lang, J. A. Kendziorski, J. M. Sroga-Rios, T. J. Herzog, and K. A. Burns, “Endometriosis: Where are we and where are we going?” Reproduction, vol. 152, no. 3, pp. R63–R78, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. R. González-Ramos, S. Defrère, and L. Devoto, “Nuclear factor-kappaB: A main regulator of inflammation and cell survival in endometriosis pathophysiology,” Fertility and Sterility, vol. 98, no. 3, pp. 520–528, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Zhang, X. Zhao, S. Liu, J. Li, Z. Wen, and M. Li, “17βE2 promotes cell proliferation in endometriosis by decreasing PTEN via NFκB-dependent pathway,” Molecular and Cellular Endocrinology, vol. 317, no. 1-2, pp. 31–43, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Ngô, C. Chéreau, C. Nicco, B. Weill, C. Chapron, and F. Batteux, “Reactive oxygen species controls endometriosis progression,” The American Journal of Pathology, vol. 175, no. 1, pp. 225–234, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. K. N. Khan, M. Kitajima, K. Hiraki et al., “Cell proliferation effect of GnRH agonist on pathological lesions of women with endometriosis, adenomyosis and uterine myoma,” Human Reproduction, vol. 25, no. 11, pp. 2878–2890, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. K. N. Khan, M. Kitajima, K. Hiraki et al., “Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy,” Human Reproduction, vol. 25, no. 3, pp. 642–653, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Erbag, M. Eroglu, H. Turkon et al., “Relationship between betatrophin levels and metabolic parameters in patients with polycystic ovary syndrome,” Cellular and Molecular Biology, vol. 62, no. 5, pp. 20–24, 2016. View at Google Scholar
  25. S. Yavuz, N. E. Aydin, O. Celik, E. Yilmaz, E. Ozerol, and K. Tanbek, “Resveratrol successfully treats experimental endometriosis through modulation of oxidative stress and lipid peroxidation,” Journal of Cancer Research and Therapeutics, vol. 10, no. 2, pp. 324–329, 2014. View at Publisher · View at Google Scholar
  26. M. A. Abbas, A. M. Disi, and M. O. Taha, “Sunitinib as an anti-endometriotic agent,” European Journal of Pharmaceutical Sciences, vol. 49, no. 4, pp. 732–736, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Yildiz, T. Kacan, O. B. Akkar et al., “Effect of imatinib on growth of experimental endometriosis in rats,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 197, pp. 159–163, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Paul, P. Bhattacharya, P. D. Mahapatra, and S. Swarnakar, “Melatonin protects against endometriosis via regulation of matrix metalloproteinase-3 and an apoptotic pathway,” Journal of Pineal Research, vol. 49, no. 2, pp. 156–168, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Hu, Z. Wang, Z. Pang et al., “Guizhi fuling capsule, an ancient Chinese formula, attenuates endometriosis in rats via induction of apoptosis,” Climacteric, vol. 17, no. 4, pp. 410–416, 2014. View at Publisher · View at Google Scholar
  30. Z. Jin, L. Wang, and Z. Zhu, “Effect of GuiXiong Xiaoyi Wan in Treatment of Endometriosis on Rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 208514, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. A. J. Hey-Cunningham, “Angiogenesis lymphangiogenesis and neurogenesis in endometriosis,” Frontiers in Bioscience, vol. E5, no. 3, pp. 1033–1056, 2013. View at Publisher · View at Google Scholar
  32. D. Djokovic and C. Calhaz-Jorge, “Angiogenesis as a Therapeutic Target in Endometriosis,” Acta Médica Portuguesa, vol. 27, no. 4, p. 489, 2014. View at Publisher · View at Google Scholar
  33. M. W. Laschke and M. D. Menger, “Anti-angiogenic treatment strategies for the therapy of endometriosis,” Human Reproduction Update, vol. 18, no. 6, Article ID dms026, pp. 682–702, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Liu, Z. Zhang, W. Xiong et al., “Hypoxia-inducible factor-1α promotes endometrial stromal cells migration and invasion by upregulating autophagy in endometriosis,” Reproduction, vol. 153, no. 6, pp. 809–820, 2017. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Xiong, Y. Liu, W. Xiong et al., “Hypoxia-inducible factor 1α-induced epithelial-mesenchymal transition of endometrial epithelial cells may contribute to the development of endometriosis,” Human Reproduction, vol. 31, no. 6, pp. 1327–1338, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. A. M. Sharkey, K. Day, A. McPherson et al., “Vascular Endothelial Growth Factor Expression in Human Endometrium Is Regulated by Hypoxia,” The Journal of Clinical Endocrinology & Metabolism, vol. 85, no. 1, pp. 402–409, 2000. View at Publisher · View at Google Scholar
  37. Q.-Z. Ren, Z.-H. Qian, S.-H. Jia, and Z.-Z. Xu, “Vascular endothelial growth factor expression up-regulated by endometrial ischemia in secretory phase plays an important role in endometriosis,” Fertility and Sterility, vol. 95, no. 8, pp. 2687–2689, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. C. M. Becker, N. Rohwer, T. Funakoshi et al., “2-Methoxyestradiol inhibits hypoxia-inducible factor-1α and suppresses growth of lesions in a mouse model of endometriosis,” The American Journal of Pathology, vol. 172, no. 2, pp. 534–544, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. Q. Yu, S. S. Zhang, and T. Zhou, “Treating non-alcoholic fatty liver disease patients of Gan stagnation Pi deficiency syndrome by tiaogan lidi recipe: a randomized controlled clinical trial,” Zhong Guo Zhong Xi Yi Jie He Za Zhi, vol. 35, no. 4, pp. 401–405, 2015. View at Google Scholar
  40. M.-H. Wu, K.-F. Chen, S.-C. Lin, C.-W. Lgu, and S.-J. Tsai, “Aberrant expression of leptin in human endometriotic stromal cells is induced by elevated levels of hypoxia inducible factor-1α,” The American Journal of Pathology, vol. 170, no. 2, pp. 590–598, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Van Langendonckt, J. Donnez, S. Defrère, G. A. J. Dunselman, and P. G. Groothuis, “Antiangiogenic and vascular-disrupting agents in endometriosis: Pitfalls and promises,” Molecular Human Reproduction, vol. 14, no. 5, pp. 259–268, 2008. View at Publisher · View at Google Scholar · View at Scopus